Terawulf [WULF] vs Morgan Stanley [MS] Detailed Stock Comparison
Terawulf
NASDAQ
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Terawulf wins in 5 metrics, Morgan Stanley wins in 11 metrics, with 0 ties. Morgan Stanley appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Terawulf | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -42.71 | 16.36 | Terawulf |
| Price-to-Book Ratio | 21.21 | 2.35 | Morgan Stanley |
| Debt-to-Equity Ratio | 287.31 | 438.54 | Terawulf |
| PEG Ratio | -0.64 | 1.01 | Terawulf |
| EV/EBITDA | -80.03 | N/A | N/A |
| Profit Margin (TTM) | -91.42% | 22.49% | Morgan Stanley |
| Operating Margin (TTM) | -21.59% | 34.12% | Morgan Stanley |
| EBITDA Margin (TTM) | N/A | 34.12% | N/A |
| Return on Equity | -46.99% | 14.13% | Morgan Stanley |
| Return on Assets (TTM) | -11.05% | 1.16% | Morgan Stanley |
| Free Cash Flow (TTM) | $-292.36M | $-2.10B | Terawulf |
| Dividend Yield | N/A | 2.15% | N/A |
| 1-Year Return | 78.09% | 41.40% | Terawulf |
| Price-to-Sales Ratio (TTM) | 24.41 | 3.52 | Morgan Stanley |
| Enterprise Value | $3.94B | $157.91B | Morgan Stanley |
| EV/Revenue Ratio | 27.32 | 2.41 | Morgan Stanley |
| Gross Profit Margin (TTM) | 53.62% | N/A | N/A |
| Revenue per Share (TTM) | $0 | $41 | Morgan Stanley |
| Earnings per Share (Diluted) | $-0.35 | $8.84 | Morgan Stanley |
| Beta (Stock Volatility) | 4.18 | 1.32 | Morgan Stanley |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Terawulf vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Terawulf | -6.40% | 67.56% | 75.95% | 119.50% | 86.02% | 60.81% |
| Morgan Stanley | -0.49% | -2.19% | 2.56% | 10.11% | 2.40% | 15.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Terawulf | 78.09% | 536.23% | 150.86% | -28.33% | 3.29% | 3.29% |
| Morgan Stanley | 41.40% | 65.96% | 172.40% | 323.11% | 475.59% | 179.42% |
Performance & Financial Health Analysis: Terawulf vs Morgan Stanley
| Metric | WULF | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $3.52B | $230.88B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 67,586,980 | 4,647,290 |
| 90 Day Avg. Volume | 53,949,567 | 5,372,360 |
| Last Close | $8.78 | $144.07 |
| 52 Week Range | $2.06 - $10.71 | $94.09 - $149.08 |
| % from 52W High | -18.02% | -3.36% |
| All-Time High | $43.98 (Nov 15, 2021) | $148.81 (Aug 15, 2025) |
| % from All-Time High | -80.04% | -3.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.11% |
| Quarterly Earnings Growth | 0.34% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.91% | 0.22% |
| Operating Margin (TTM) | -0.22% | 0.34% |
| Return on Equity (TTM) | -0.47% | 0.14% |
| Debt to Equity (MRQ) | 287.31 | 438.54 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.42 | $61.59 |
| Cash per Share (MRQ) | $0.23 | $352.68 |
| Operating Cash Flow (TTM) | $-61,972,000 | $-17,670,000,640 |
| Levered Free Cash Flow (TTM) | $-205,312,496 | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.15% |
| Last 12-Month Dividend | $0.00 | $2.79 |
Valuation & Enterprise Metrics Analysis: Terawulf vs Morgan Stanley
| Metric | WULF | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -42.71 | 16.36 |
| Forward P/E | 89.70 | 18.24 |
| PEG Ratio | -0.64 | 1.01 |
| Price to Sales (TTM) | 24.41 | 3.52 |
| Price to Book (MRQ) | 21.21 | 2.35 |
| Market Capitalization | ||
| Market Capitalization | $3.52B | $230.88B |
| Enterprise Value | $3.94B | $157.91B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 27.32 | 2.41 |
| Enterprise to EBITDA | -80.03 | N/A |
| Risk & Other Metrics | ||
| Beta | 4.18 | 1.32 |
| Book Value per Share (MRQ) | $0.42 | $61.59 |
Financial Statements Comparison: Terawulf vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WULF | MS |
|---|---|---|
| Revenue/Sales | $34.41M | $16.52B |
| Cost of Goods Sold | $24.55M | N/A |
| Gross Profit | $9.85M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-59.63M | N/A |
| EBITDA | $-41.11M | N/A |
| Pre-Tax Income | $-61.42M | $5.54B |
| Income Tax | $0 | $1.17B |
| Net Income (Profit) | $-61.42M | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WULF | MS |
|---|---|---|
| Cash & Equivalents | $218.16M | $60.84B |
| Total Current Assets | $230.05M | N/A |
| Total Current Liabilities | $120.93M | N/A |
| Long-Term Debt | $491.82M | $303.93B |
| Total Shareholders Equity | $170.38M | $107.85B |
| Retained Earnings | $-393.69M | $107.65B |
| Property, Plant & Equipment | $380.99M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WULF | MS |
|---|---|---|
| Operating Cash Flow | $54.55M | $-67.29B |
| Capital Expenditures | $-93.69M | $-713.00M |
| Free Cash Flow | $-37.20M | $-24.69B |
| Debt Repayment | $0 | $-20.85B |
| Common Stock Repurchase | $-33.29M | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | WULF | MS |
|---|---|---|
| Shares Short | 88.11M | 14.60M |
| Short Ratio | 1.72 | 2.55 |
| Short % of Float | 0.27% | 0.01% |
| Average Daily Volume (10 Day) | 67,586,980 | 4,647,290 |
| Average Daily Volume (90 Day) | 53,949,567 | 5,372,360 |
| Shares Outstanding | 385.65M | 1.61B |
| Float Shares | 292.60M | 1.21B |
| % Held by Insiders | 0.26% | 0.24% |
| % Held by Institutions | 0.58% | 0.63% |
Dividend Analysis & Yield Comparison: Terawulf vs Morgan Stanley
| Metric | WULF | MS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $2.79 |
| Last 12-Month Dividend Yield | N/A | 2.15% |
| 3-Year Avg Annual Dividend | $0.00 | $3.10 |
| 3-Year Avg Dividend Yield | N/A | 0.90% |
| 3-Year Total Dividends | $0.00 | $9.31 |
| Ex-Dividend Date | N/A | Jan 31, 2025 |